1. Alfredo,Berruti 意大利 University of Brescia The Evolving Treatment Landscape of Medullary Thyroid Cancer
2. Andrew M,Smith 美国 University of Illinois at Urbana-Champaign Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid patholog..
3. Florian,Lordick 德国 University of Leipzig Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract
4. Roecken, Christoph 德国 University of Kiel Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract
5. David,Cibula 捷克共和国 Charles University Prague Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases compa..
6. 薛红卫 中国 上海交通大学 Data-independent acquisition-based global phosphoproteomics reveal the diverse roles of casein kinas..
7. 卢大儒 中国 复旦大学 教授 Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
8. Thomas,Becker 德国 Technical University of Munich LAG3 in gastric cancer: it's complicated
9. Roecken, Christoph 德国 University of Kiel LAG3 in gastric cancer: it's complicated
10. Michael J,MacCoss 美国 University of Washington Proteogenomic data and resources for pan-cancer analysis
11. Hui,Zhang 美国 Johns Hopkins University Proteogenomic data and resources for pan-cancer analysis
12. Gad,Getz 美国 Massachusetts Institute of Technology, MIT Proteogenomic data and resources for pan-cancer analysis
13. Li,Ding 美国 University of Washington Proteogenomic data and resources for pan-cancer analysis
14. Alexey I,Nesvizhskii 美国 University of Michigan Proteogenomic data and resources for pan-cancer analysis
15. Bing,Zhang 美国 Baylor College of Medicine Proteogenomic data and resources for pan-cancer analysis
16. Rossella,Elisei 意大利 University of Pisa NF1 gene inactivation acts as a tumor driver in RET/RAS-negative medullary thyroid carcinomas
17. Elizabeth C,Smyth 英国 ROYAL MARSDEN Hospital Immunotherapy in Gastro-Oesophageal Cancer: Current Practice and the Future of Personalised Therapy
18. Fran,Supek 西班牙 RUDJER BOSKOVIC Institute Mutational signatures are markers of drug sensitivity of cancer cells
19. Ryuji,Hamamoto 日本 University of TOKYO Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid c..
20. Kohno, Takashi 日本 National Cancer Center Research Institute Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid c..